Construction crews have broken ground on the Origins Carbon Capture and Storage hub near Clive, Alberta, following the completion of detailed engineering work by Calgary-based Gas Liquids Engineering. The infrastructure project, designed to transport and sequester CO₂ emissions, is scheduled to reach full operational capacity by early 2027.
Dallas-based technology platform Axxess has joined forces with the National Partnership for Healthcare and Hospice Innovation (NPHI) to integrate specialized digital tools into nonprofit advanced illness care. The collaboration aims to help providers manage complex regulatory shifts while maintaining a focus on patient-centered, community-based service delivery.
With over 200 court appearances to her credit, Monica Caswell is bringing her Florida-based boutique, Forensic Accountants & Consultants, into the global fold of J.S. Held. The move signals a strategic push to bolster the firm’s litigation support and asset tracing capabilities for high-stakes marital and commercial disputes.
Canela Media is shifting how brands target U.S. Hispanic consumers by launching six proprietary culture-based audience segments. Now available via Canela Audience Solutions, these cohorts allow marketers to move beyond basic demographics, focusing instead on how individual consumers express, navigate, and engage with their cultural identity in daily life.
Orange, California—GreenFruit Avocados is betting on a mix of industry veteran experience and internal institutional knowledge to master the final mile of its supply chain. The company appointed Ryan C. Fink as Vice President of Operations while elevating Giovanni Espinosa and Andrew Gomez to key managerial roles to bolster global logistics.
The American Rhinologic Society has tapped the FLAVOR trial for the opening slot of its 72nd annual meeting in Los Angeles. The presentation will detail how CYR-064, a theophylline nasal spray, performed in a Phase 2 study aimed at restoring olfactory function in patients suffering from persistent post-viral hyposmia.
With a grant of 241,920 euros, Swedish developer Metacon is set to launch the BIOH2VAP initiative in Ierapetra, Crete. The project centers on a pilot plant designed to transform agricultural and livestock biogas into high-purity hydrogen, testing the commercial viability of the company’s proprietary reforming technology in an industrial setting.
Vinci Pharmaceuticals has closed an $8 million Series A funding round, bringing its total capital raised to over $16.5 million. The New Jersey-based company is developing EPIPLANT, an episcleral drug delivery platform designed to replace traditional, high-burden intraocular injections with a sustained-release, needle-free alternative for treating retinal diseases.
With over $16.5 million in total funding now secured, New Jersey-based Vinci Pharmaceuticals is pivoting toward human trials for its EPIPLANT drug delivery system. The company closed an $8 million Series A round to fund manufacturing and pre-clinical development ahead of a scheduled 2027 Phase 1/2a clinical study.
From 2,000 users to 15,000 in a single year, New York-based Vocca is betting that conversational AI holds the key to solving medical administrative burnout. The startup just closed a $20 million Series A round led by Norrsken VC, bringing its total capital raised to $25 million.
Too many residents in Harris County currently fall through the cracks of fragmented support systems, prompting a coalition of six major health organizations to launch the Harris Collaborative. By integrating data and services, the initiative aims to bridge critical gaps in care for those with the most complex medical needs.
Viatris Inc. has entered a definitive agreement to acquire Pacira BioSciences for $36.50 per share in cash, a deal valued at $1.65 billion. The acquisition secures two high-margin, patent-protected non-opioid pain therapies, EXPAREL and ZILRETTA, as Viatris looks to expand its footprint in specialized medicine.
Generative AI has transformed phishing from a game of pattern recognition into a high-speed arms race, rendering traditional security filters obsolete. AegisAI is responding with Proteus, a foundational model that abandons signature-based detection to perform an autonomous, SOC-style investigation on every incoming email before it hits the inbox.
Arthur Giterman is stepping down as CEO and CFO of Mynd.ai effective October 11, 2026, marking a sudden leadership transition for the interactive technology firm. The board has appointed veteran tech executive Bin Shen to take the helm as CEO and interim financial chief starting the following day.
With a waiting list of 6,000 students vying for fewer than 600 seats, Valor Education has secured a $500,000 award as a Yass Prize finalist. The classical charter network, which serves 5,000 students across Texas, earned the recognition for its rapid expansion and high family satisfaction rates.
More than 200 global investment teams at Balyasny Asset Management are now utilizing Google’s Gemini models to accelerate complex financial analysis. By embedding these models into proprietary platforms like BAMAgent, the firm aims to automate the ingestion and synthesis of thousands of weekly market reports, earnings transcripts, and regulatory filings.
London played host to the international premiere of the Cohiba Talismán, the latest addition to the brand's Línea Clásica. This launch serves as the inaugural milestone in a year-long celebration marking the 60th anniversary of the world's most recognizable premium tobacco brand, setting the stage for a series of commemorative releases.
El Segundo-based Gallatin AI has raised $50 million in Series A funding to scale its military logistics software. The company, which builds predictive tools for the Joint Logistics Enterprise, plans to use the capital to expand its engineering team and broaden the capabilities of its flagship Navigator platform.
Faced with the mounting burden of chronic illness and compressed clinic schedules, the American College of Lifestyle Medicine has released a consensus statement advocating for shared medical appointments. The model aims to replace isolated consultations with group-based care, combining individualized medical attention with peer support and sustained lifestyle intervention.
At Jakarta’s Spac8 ASHTA, beauty brand Wardah has launched the Skinverse 2026: Skin Longevity Clinic, an immersive installation designed to fuse lifestyle habits with dermatological science. Running through October 6, the project seeks to pivot the national beauty conversation from reactive problem-solving toward long-term skin resilience and holistic wellness.
Actress Viola Davis is going public with her personal battle against shingles, headlining a new GSK campaign titled "Shingles, actually." The initiative aims to push adults over 50 to look past their active lifestyles and recognize that aging naturally elevates their risk for the painful, blistering condition.
As businesses race to integrate artificial intelligence, the resulting expansion of attack surfaces has left many firms exposed to outdated or misconfigured defenses. Coral Gables-based ERMProtect is responding to this landscape with a diagnostic tool designed to map internal controls against over 100 industry-recognized security frameworks.
Reston-based defense contractor V2X, Inc. will disclose its financial performance for the third quarter of 2026 on Monday, November 2, following the close of regular market trading. Senior executives are scheduled to discuss the results and broader company strategy during a conference call starting at 4:30 p.m. ET that same afternoon.
Saol Therapeutics has finalized patient recruitment for its pivotal Phase III BEACON trial, testing the experimental injection SL1002 as a non-opioid remedy for chronic knee pain caused by osteoarthritis. The company now pivots toward regulatory discussions with the FDA regarding a second potential use for the drug targeting spasticity.
Insu Therapeutics has received a Notice of Allowance from the USPTO for its buccal peptide-delivery technology, a key step toward replacing injections with a non-invasive alternative for diabetes and metabolic disease patients.
The first patient has received a dose of NVC-001 in the SUNBEAM-LMNA clinical trial, marking a pivotal shift in testing gene therapies for the aggressive heart condition. Alongside the trial launch, the FDA granted the treatment Fast Track designation to accelerate development for a disease that currently lacks approved therapies.
Insu Therapeutics has received a Notice of Allowance from the USPTO for its buccal peptide-delivery technology, a move that bolsters the intellectual property foundation for the company’s needle-free insulin and GLP-1 formulations. Hydreight Technologies, which holds a strategic stake in the biotech firm, maintains rights for future U.S. distribution.
Keenova Therapeutics is set to present fresh clinical data and communication tools at the Sexual Medicine Society of North America annual meeting, running October 8-11, 2026. The company’s sessions focus on advancing non-surgical options for Peyronie’s disease and improving patient-clinician dialogue regarding sexual health.
GreenLight Fund’s latest impact report shows its portfolio organizations supported 1.6 million individuals and families during the 2025-2026 fiscal year. By expanding into Dallas, the nonprofit grew its national footprint to 15 cities, leveraging $47.8 million in direct investments to unlock $454 million in follow-on funding.
DiamondRock Hospitality Company has expanded its leisure-focused portfolio by acquiring the 79-room Bellmoor Inn & Spa in Rehoboth Beach, Delaware. The deal, valued at $31 million, underscores the firm's strategy to capture growth in supply-constrained coastal markets through targeted asset management and capital improvements.
